INSMED INC (INSM)       21.37  +0.4 (+1.91%)

21.37  +0.4 (+1.91%)

US4576693075 - Common Stock - After market: 21.37 0 (0%)

News Image
a month ago - Market News Video

Insmed (INSM) Shares Cross Below 200 DMA

News Image
a month ago - Market News Video

INSM December 2023 Options Begin Trading

News Image
2 months ago - Insmed Incorporated

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

News Image
2 months ago - Insmed Incorporated

Insmed Reports Second Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

News Image
2 months ago - Insmed Incorporated

Insmed to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022

/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

News Image
3 months ago - Insmed Incorporated

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

News Image
4 months ago - Insmed Incorporated

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

News Image
4 months ago - Insmed Incorporated

Insmed Presents New Data Across Three Pillars at American Thoracic Society 2022 International Conference

/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

News Image
5 months ago - Insmed Incorporated

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

News Image
5 months ago - Insmed Incorporated

Insmed Reports First Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

News Image
6 months ago - Insmed Incorporated

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

News Image
7 months ago - Insmed Incorporated

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

News Image
7 months ago - Insmed Incorporated

Insmed To Present at the Cowen 42nd Annual Health Care Conference

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...